Antibody reply soon after very first as well as second-dose associated with ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among healthcare workers inside India: The end result associated with cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study.